Niagen Bioscience, Inc. (NAGE)vsTarget Corporation (TGT)
NAGE
Niagen Bioscience, Inc.
$3.04
+0.16%
CONSUMER DEFENSIVE · Cap: $240.15M
TGT
Target Corporation
$155.83
+0.06%
CONSUMER DEFENSIVE · Cap: $70.79B
Smart Verdict
WallStSmart Research — data-driven comparison
Target Corporation generates 83338% more annual revenue ($107.70B vs $129.08M). NAGE leads profitability with a 12.4% profit margin vs 4.1%. NAGE trades at a lower P/E of 16.0x. TGT earns a higher WallStSmart Score of 66/100 (B-).
NAGE
Hold40
out of 100
Grade: D
TGT
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for NAGE.
Margin of Safety
+5.3%
Fair Value
$120.98
Current Price
$155.83
$34.85 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Every $100 of equity generates 23 in profit
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 100.5% YoY
Large-cap with strong market position
Every $100 of equity generates 25 in profit
Attractively priced relative to earnings
Generating 2.4B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 2.4%
Revenue declined 4.3%
Earnings declined 75.0%
Expensive relative to growth rate
4.1% margin — thin
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : NAGE
The strongest argument for NAGE centers on Debt/Equity, Return on Equity, P/E Ratio.
Bull Case : TGT
The strongest argument for TGT centers on EPS Growth, Market Cap, Return on Equity.
Bear Case : NAGE
The primary concerns for NAGE are Market Cap, Operating Margin, Revenue Growth.
Bear Case : TGT
The primary concerns for TGT are PEG Ratio, Profit Margin, Debt/Equity. Thin 4.1% margins leave little buffer for downturns.
Key Dynamics to Monitor
NAGE profiles as a declining stock while TGT is a value play — different risk/reward profiles.
NAGE carries more volatility with a beta of 2.09 — expect wider price swings.
TGT is growing revenue faster at 5.3% — sustainability is the question.
TGT generates stronger free cash flow (2.4B), providing more financial flexibility.
Bottom Line
TGT scores higher overall (66/100 vs 40/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Niagen Bioscience, Inc.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
Target Corporation
CONSUMER DEFENSIVE · DISCOUNT STORES · USA
Target Corporation is an American retail corporation. Their retail formats include the discount store Target, the hypermarket SuperTarget, and small-format stores previously named CityTarget and TargetExpress before being consolidated under the Target branding.
Compare with Other PACKAGED FOODS Stocks
Want to dig deeper into these stocks?